Renaissance of Radiotherapy in Intestinal Lymphoma? 10-Year Efficacy and Tolerance in Multimodal Treatment of 134 Patients: Follow-up of Two German Multicenter Consecutive Prospective Phase II Trials.

Gabriele Reinartz; Caroline Molavi Tabrizi; Ruediger Liersch; Hansjoerg Ullerich; Dominik Hering; Kay Willborn; Juergen Schultze; Oliver Micke; Christian Ruebe; Wolfgang Fischbach; Martin Bentz; Severin Daum; Christiane Pott; Markus Tiemann; Peter Moeller; Andreas Neubauer; Martin Wilhelm; Georg Lenz; Wolfgang E Berdel; Normann Willich; Hans T Eich

doi:10.1634/theoncologist.2019-0783

Renaissance of Radiotherapy in Intestinal Lymphoma? 10-Year Efficacy and Tolerance in Multimodal Treatment of 134 Patients: Follow-up of Two German Multicenter Consecutive Prospective Phase II Trials.

Gabriele Reinartz, Caroline Molavi Tabrizi, Ruediger Liersch, Hansjoerg Ullerich, Dominik Hering, Kay Willborn, Juergen Schultze, Oliver Micke, Christian Ruebe, Wolfgang Fischbach, Martin Bentz, Severin Daum, Christiane Pott, Markus Tiemann, Peter Moeller, Andreas Neubauer, Martin Wilhelm (Co-author), Georg Lenz, Wolfgang E Berdel, Normann WillichHans T Eich

Department of Internal Medicine V, Division of Oncology and Hematology

Research output: Contribution to journal › Original Article › peer-review

4 Citations (Web of Science)

Original language	English
Pages (from-to)	e816-e832
Journal	ONCOLOGIST
Volume	25
Issue number	5
DOIs	https://doi.org/10.1634/theoncologist.2019-0783
Publication status	Published - 2020

Keywords

NON-HODGKINS-LYMPHOMA
MARGINAL ZONE LYMPHOMA
GASTROINTESTINAL LYMPHOMAS
RADIATION-THERAPY
CLINICAL-FEATURES
DIAGNOSIS
GUIDELINES
MANAGEMENT
OUTCOMES
RELAPSE

Access to Document

10.1634/theoncologist.2019-0783

Cite this

Reinartz, G., Molavi Tabrizi, C., Liersch, R., Ullerich, H., Hering, D., Willborn, K., Schultze, J., Micke, O., Ruebe, C., Fischbach, W., Bentz, M., Daum, S., Pott, C., Tiemann, M., Moeller, P., Neubauer, A., Wilhelm, M., Lenz, G., Berdel, W. E., ... Eich, H. T. (2020). Renaissance of Radiotherapy in Intestinal Lymphoma? 10-Year Efficacy and Tolerance in Multimodal Treatment of 134 Patients: Follow-up of Two German Multicenter Consecutive Prospective Phase II Trials. ONCOLOGIST, 25(5), e816-e832. https://doi.org/10.1634/theoncologist.2019-0783

@article{3b739738f5454475beaba159caf38ad2,

title = "Renaissance of Radiotherapy in Intestinal Lymphoma? 10-Year Efficacy and Tolerance in Multimodal Treatment of 134 Patients: Follow-up of Two German Multicenter Consecutive Prospective Phase II Trials.",

keywords = "NON-HODGKINS-LYMPHOMA, MARGINAL ZONE LYMPHOMA, GASTROINTESTINAL LYMPHOMAS, RADIATION-THERAPY, CLINICAL-FEATURES, DIAGNOSIS, GUIDELINES, MANAGEMENT, OUTCOMES, RELAPSE",

author = "Gabriele Reinartz and {Molavi Tabrizi}, Caroline and Ruediger Liersch and Hansjoerg Ullerich and Dominik Hering and Kay Willborn and Juergen Schultze and Oliver Micke and Christian Ruebe and Wolfgang Fischbach and Martin Bentz and Severin Daum and Christiane Pott and Markus Tiemann and Peter Moeller and Andreas Neubauer and Martin Wilhelm and Georg Lenz and Berdel, {Wolfgang E} and Normann Willich and Eich, {Hans T}",

note = "Wilhelm: Paracelsus Med Univ, Klinikum Nuernberg, Dept Med Oncol, Nurnberg, Germany",

year = "2020",

doi = "10.1634/theoncologist.2019-0783",

language = "English",

volume = "25",

pages = "e816--e832",

journal = "ONCOLOGIST",

issn = "1083-7159",

number = "5",

}

Reinartz, G, Molavi Tabrizi, C, Liersch, R, Ullerich, H, Hering, D, Willborn, K, Schultze, J, Micke, O, Ruebe, C, Fischbach, W, Bentz, M, Daum, S, Pott, C, Tiemann, M, Moeller, P, Neubauer, A, Wilhelm, M, Lenz, G, Berdel, WE, Willich, N & Eich, HT 2020, 'Renaissance of Radiotherapy in Intestinal Lymphoma? 10-Year Efficacy and Tolerance in Multimodal Treatment of 134 Patients: Follow-up of Two German Multicenter Consecutive Prospective Phase II Trials.', ONCOLOGIST, vol. 25, no. 5, pp. e816-e832. https://doi.org/10.1634/theoncologist.2019-0783

Renaissance of Radiotherapy in Intestinal Lymphoma? 10-Year Efficacy and Tolerance in Multimodal Treatment of 134 Patients: Follow-up of Two German Multicenter Consecutive Prospective Phase II Trials. / Reinartz, Gabriele; Molavi Tabrizi, Caroline; Liersch, Ruediger et al.
In: ONCOLOGIST, Vol. 25, No. 5, 2020, p. e816-e832.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Renaissance of Radiotherapy in Intestinal Lymphoma? 10-Year Efficacy and Tolerance in Multimodal Treatment of 134 Patients: Follow-up of Two German Multicenter Consecutive Prospective Phase II Trials.

AU - Reinartz, Gabriele

AU - Molavi Tabrizi, Caroline

AU - Liersch, Ruediger

AU - Ullerich, Hansjoerg

AU - Hering, Dominik

AU - Willborn, Kay

AU - Schultze, Juergen

AU - Micke, Oliver

AU - Ruebe, Christian

AU - Fischbach, Wolfgang

AU - Bentz, Martin

AU - Daum, Severin

AU - Pott, Christiane

AU - Tiemann, Markus

AU - Moeller, Peter

AU - Neubauer, Andreas

AU - Wilhelm, Martin

AU - Lenz, Georg

AU - Berdel, Wolfgang E

AU - Willich, Normann

AU - Eich, Hans T

N1 - Wilhelm: Paracelsus Med Univ, Klinikum Nuernberg, Dept Med Oncol, Nurnberg, Germany

PY - 2020

Y1 - 2020

KW - NON-HODGKINS-LYMPHOMA

KW - MARGINAL ZONE LYMPHOMA

KW - GASTROINTESTINAL LYMPHOMAS

KW - RADIATION-THERAPY

KW - CLINICAL-FEATURES

KW - DIAGNOSIS

KW - GUIDELINES

KW - MANAGEMENT

KW - OUTCOMES

KW - RELAPSE

U2 - 10.1634/theoncologist.2019-0783

DO - 10.1634/theoncologist.2019-0783

M3 - Original Article

C2 - 32219909

SN - 1083-7159

VL - 25

SP - e816-e832

JO - ONCOLOGIST

JF - ONCOLOGIST

IS - 5

ER -